David Michael Wagenbach

This inventor holds 18 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 11 EPO patents. Top assignee: Boston Scientific Neuromodulation Corporation. Active years: 2020-2026.

USPTO Granted Patents = 18 (Patent Applications = 3)

% Patents Active = 100.0

CIPO Patents = 2

EPO Patents = 11 (Patent Applications = 15)

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 24(Granted Patents)

Company Filing History:

18 out of 1,659

Boston Scientific Neuromodulation Corporation

patents

Years Active: 2020-2026

Loading Chart...

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12714867 - Current generation architecture for an implantable stimulator device including distributor circuitry for sending an amplitude-scaled current to digital-to-analog converters at the electrodes (2026-08-25),

2. 12576276 - Amplitude modulating waveform pattern generation for stimulation in an implantable pulse generator (2026-03-17),

3. 12370359 - Pulse definition circuitry for creating stimulation waveforms in an implantable pulse generator (2025-07-29),

4. 12257436 - Neural sensing in an implantable stimulator device during passive charge recovery (2025-03-25),

5. 12017074 - Adjustment of stimulation in a stimulator using detected evoked compound action potentials (2024-06-25),

6. 11793999 - Pulse definition circuitry for creating stimulation waveforms in an implantable pulse generator (2023-10-24),

7. 11793438 - Neural sensing in an implantable stimulator device during the provision of active stimulation (2023-10-24),

8. 11724114 - Current generation architecture for an implantable stimulator device including distributor circuitry for sending an amplitude-scaled current to digital-to-analog converters at the electrodes (2023-08-15),

9. 11697021 - Current generation architecture for an implantable stimulator device to promote current steering between electrodes (2023-07-11),

10. 11565117 - Amplitude modulating waveform pattern generation for stimulation in an implantable pulse generator (2023-01-31),

11. 11259733 - Neural sensing in an implantable stimulator device during the provision of active stimulation (2022-03-01),

12. 11129987 - Adjustment of stimulation in a stimulator using detected evoked compound action potentials (2021-09-28),

13. 10912942 - Current generation architecture for an implantable stimulator device to promote current steering between electrodes (2021-02-09),

14. 10786665 - Biasing of a current generation architecture for an implantable medical device (2020-09-29),

15. 10780285 - Current generation architecture for an implantable stimulator device including distributor circuitry for sending an amplitude-scaled current to digital-to-analog converters at the electrodes (2020-09-22),

Title: David Michael Wagenbach: Innovator in Implantable Stimulation Technology

Introduction

David Michael Wagenbach is a prominent inventor based in Simi Valley, California. He has made significant contributions to the field of neuromodulation, holding a total of 16 patents. His work primarily focuses on developing advanced technologies for implantable stimulators, which have the potential to improve therapeutic outcomes for patients.

Latest Patents

Wagenbach's latest patents include innovative designs for pulse definition circuitry in implantable pulse generators. This technology enhances stimulation circuitry by incorporating memory circuitry that stores pulse programs, steering programs, and aggregate programs. These programs work together to define pulse shapes and electrode configurations, allowing for precise control of stimulation delivered by the device. Another notable patent involves techniques for neural sensing in implantable stimulators during passive charge recovery. This method allows for the sensing of neural responses, such as Evoked Compound Action Potentials (ECAPs), during a high-impedance passive charge recovery phase, optimizing the timing and effectiveness of the stimulation.

Career Highlights

Wagenbach is currently employed at Boston Scientific Neuromodulation Corporation, where he continues to innovate in the field of medical technology. His extensive experience and expertise have positioned him as a key player in the development of advanced neuromodulation devices.

Collaborations

Throughout his career, Wagenbach has collaborated with notable colleagues, including Philip Leonard Weiss and Goran Nils Marnfeldt. These partnerships have contributed to the advancement of technologies in the neuromodulation sector.

Conclusion

David Michael Wagenbach's contributions to implantable stimulation technology demonstrate his commitment to improving patient care through innovation. His patents reflect a deep understanding of the complexities involved in neuromodulation, and his work continues to influence the field significantly.

Profile summary based on public USPTO records.

Please report any incorrect information to [email protected]